96 related articles for article (PubMed ID: 1375852)
1. In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64.
Jani JP; Mistry JS; Morris G; Lazo JS; Sebti SM
Oncol Res; 1992; 4(2):59-63. PubMed ID: 1375852
[TBL] [Abstract][Full Text] [Related]
2. In vivo circumvention of human colon carcinoma resistance to bleomycin.
Jani JP; Mistry JS; Morris G; Davies P; Lazo JS; Sebti SM
Cancer Res; 1992 May; 52(10):2931-7. PubMed ID: 1374681
[TBL] [Abstract][Full Text] [Related]
3. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.
Morris G; Mistry JS; Jani JP; Sebti SM; Lazo JS
Biochem Pharmacol; 1991 Jun; 41(11):1559-66. PubMed ID: 1710457
[TBL] [Abstract][Full Text] [Related]
5. Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.
Pei Z; Calmels TP; Creutz CE; Sebti SM
Mol Pharmacol; 1995 Oct; 48(4):676-81. PubMed ID: 7476893
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
[TBL] [Abstract][Full Text] [Related]
7. Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.
Sacchi A; Calabresi F; Greco C; Zupi G
Invasion Metastasis; 1981; 1(4):227-38. PubMed ID: 6203864
[TBL] [Abstract][Full Text] [Related]
8. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
Harrison JH; Hoyt DG; Lazo JS
Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
[TBL] [Abstract][Full Text] [Related]
9. [Combined effect of bleomycin and SDB-ethylenediamine, a synthetic isoprenoid, on oral squamous carcinoma cell lines and transplantable nude mouse tumors].
Takahashi Y; Urade M; Kishimoto H; Arimoto T; Yanagisawa T; Yoshioka W
Gan To Kagaku Ryoho; 1995 Jun; 22(7):883-7. PubMed ID: 7540824
[TBL] [Abstract][Full Text] [Related]
10. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
[TBL] [Abstract][Full Text] [Related]
11. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice.
Horiuchi A; Nikaido T; Mitsushita J; Toki T; Konishi I; Fujii S
Int J Cancer; 2000 Nov; 88(4):640-4. PubMed ID: 11058883
[TBL] [Abstract][Full Text] [Related]
13. Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice.
Jääskelä-Saari HA; Grénman R; Ramsay HA; Tarkkanen J; Paavonen T; Kairemo KJ
Cancer Biother Radiopharm; 2005 Aug; 20(4):426-35. PubMed ID: 16114991
[TBL] [Abstract][Full Text] [Related]
14. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin induced changes in growth and cell kinetics of a heterotransplanted squamous cell carcinoma of the head and neck.
Wennerberg J
Anticancer Res; 1984; 4(6):419-23. PubMed ID: 6083742
[TBL] [Abstract][Full Text] [Related]
16. Host immune responses to tumor cells augmented by bleomycin and their therapeutic effects on rat fibrosarcoma.
Hosokawa M; Xu ZY; Morikawa K; Hamada J; Kobayashi H
Mol Biother; 1988; 1(2):74-80. PubMed ID: 2479397
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
19. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
20. Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery.
Norum OJ; Gaustad JV; Angell-Petersen E; Rofstad EK; Peng Q; Giercksky KE; Berg K
Photochem Photobiol; 2009; 85(3):740-9. PubMed ID: 19076314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
